COPPELL, Texas--(BUSINESS WIRE)--Mannatech, Incorporated (NASDAQ: MTEX), the leading innovator and provider of naturally sourced supplements based on Real Food Technology® solutions, announced today the publication of a study on The Effect of Dietary Supplements on the Quality of Life of Retired Professional Football Players. The study was published in the Global Journal of Health Science, Vol. 5, No. 2, 2013¹, e-Version FirstTM. http://www.ccsenet.org/journal/index.php/gjhs/article/view/21748
“We’re excited and encouraged by the results of this study”
The open-label human clinical study showed that intake of Mannatech products resulted in statistically significant positive findings of general improvements in quality of life, satisfaction with health and physical and mental health of retired professional football players who used dietary supplements*†. The 15 retired football players who participated in the study took Mannatech’s Ambrotose® Complex powder, Omega-3 with Vitamin D3, Ambrotose AO® capsules, PhytoMatrix® caplets and PLUS™ caplets. Review of current scientific literature reveals that this is one of the few studies conducted on dietary supplementation and quality of life in retired football players using well-validated outcome measures.
“We’re excited and encouraged by the results of this study,” explained Dr. Robert A. Sinnott, CEO and Chief Science Officer for Mannatech, Inc. “There have been various studies on dietary supplements released over the past couple years that have seemed, at times, confusing and even contradictory. The findings among this group of retired professional football players is significant in that it measures what most people are looking for in dietary supplements in the first place: an improved quality of life. Our company is founded on providing advanced nutritional technologies based on real-food sources that lead to definitive improvements in well-being. This study clearly supports our approach.”
The study was authored by Dr. Robert A. Sinnott, Dr. Rolando L. Maddela, Dr. Sejong Bae and Dr. Talitha Best. Dr. Sinnott is the CEO and Chief Science Officer at Mannatech, and Dr. Maddela is the Clinical Research Administration Manager at Mannatech. Dr. Bae was a Professor in the Department of Biostatistics at the University of North Texas Health Science Center’s School of Public Health in Fort Worth, Texas (he is now affiliated with University of Alabama at Birmingham); Dr. Best was a Research Fellow in the Nutritional Physiology Research Center, Sansom Institute for Health Research, University of South Australia, Adelaide, South Australia (she is now affiliated with Central Queensland U. at Bundaberg).
*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
†This study was funded by Mannatech, Incorporated.
¹ Sinnott, R.A., Maddela, R.L., Bae, S., & Best, T. The Effect of Dietary Supplements on the Quality of Life of Retired Professional Football Players. Global Journal of Health Science 2013; Vol.5, No.2 (e-Version FirstTM). Published online November 22, 2012.
Mannatech, Incorporated, develops high-quality health, weight and fitness, and skincare products that are based on the solid foundation of nutritional science and development standards. Mannatech is dedicated to its platform of Social Entrepreneurship based on the foundation of promoting, aiding and optimizing nutrition where it is needed most around the world. Mannatech’s proprietary products are available through independent sales Associates around the globe including the United States, Canada, South Africa, Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan, Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech Republic, the Republic of Korea, Mexico and Namibia. For more information, visit Mannatech.com.
Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain Associates and Members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.